Terms: = Thyroid cancer AND CREB3L2, MGC131709, 64764, ENSG00000182158, TCAG_1951439, BBF2H7, MGC71006
4 results:
1. Somatic Mutation Profiling of Papillary thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.
Qi T; Rong X; Feng Q; Sun H; Cao H; Yang Y; Feng H; Zhu L; Wang L; Du Q
Int J Med Sci; 2021; 18(12):2532-2544. PubMed ID: 34104084
[TBL] [Abstract] [Full Text] [Related]
2. Determination of the mutational landscape in Taiwanese patients with papillary thyroid cancer by whole-exome sequencing.
Chang CC; Chang YS; Huang HY; Yeh KT; Liu TC; Chang JG
Hum Pathol; 2018 Aug; 78():151-158. PubMed ID: 29753010
[TBL] [Abstract] [Full Text] [Related]
3. Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma.
McFadden DG; Dias-Santagata D; Sadow PM; Lynch KD; Lubitz C; Donovan SE; Zheng Z; Le L; Iafrate AJ; Daniels GH
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2457-62. PubMed ID: 25148236
[TBL] [Abstract] [Full Text] [Related]
4. creb3l2-PPARgamma fusion mutation identifies a thyroid signaling pathway regulated by intramembrane proteolysis.
Lui WO; Zeng L; Rehrmann V; Deshpande S; Tretiakova M; Kaplan EL; Leibiger I; Leibiger B; Enberg U; Höög A; Larsson C; Kroll TG
Cancer Res; 2008 Sep; 68(17):7156-64. PubMed ID: 18757431
[TBL] [Abstract] [Full Text] [Related]
